Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The University of Texas Health Science Center, Houston
Age
18–45
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Female subjects, ages 18-45 years
Experienced a major depressive episode in the postpartum period beginning within the first 4 weeks following delivery and with moderate or severe symptoms (\>12 EPDS or \>14 HAM-D).
No or partial response to adequate doses of SSRI medications to treat PND for longer than 6 weeks.
PND patients will be requested to maintain the stable dose of antidepressants while enrolled in the study trial.
Patients that can speak and read the English language, are able to understand the study procedures and sign the informed consent
You may not be if
No current or past psychosis or severe personality disorder.
No current substance abuse or dependence.
No serious and imminent suicidal or homicidal risk.
No recent or history of major and unstable medical problems that affect brain anatomy, neurochemistry, or function.
Not diagnosed with cardiovascular disorders.
No increased risk of laryngospasm or active upper respiratory infections.
Not diagnosed with an intellectual disability or neurodegenerative diseases.
Mothers that are currently breastfeeding.
No current pregnancy.
Clareo Health | Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression
